1 - 25 of 186 Items

Guidelines / Expert consensus2023, feb 22

Guidelines for the diagnosis and management of osteoporosis in Poland. Update 2022

Piotr Głuszko, Ewa Sewerynek, Waldemar Misiorowski, Jerzy Konstantynowicz, Ewa Marcinowska-Suchowierska, Tomasz Blicharski, Mirosław Jabłoński, Edward Franek, Tomasz Kostka, Maciej Jaworski, Elżbieta Karczmarewicz, Ewa Kalinka, Krystyna Księżopolska-Orłowska, Andrzej Więcek, Roman S. Lorenc

Vol 74, No 1 (2023)

Guidelines / Expert consensus

Pubmed: 36847720
Endokrynol Pol 2023;74(1):5-15.
Guidelines / Expert consensus2023, feb 23

Basics of prevention and management of iodine-based contrast media-induced thyroid dysfunction — position paper by the Polish Society of Endocrinology

Tomasz Bednarczuk, Dariusz Kajdaniuk, Bogdan Marek, Marek Bolanowski, Marek Dedecjus, Aleksandra Gilis-Januszewska, Alicja Hubalewska-Dydejczyk, Barbara Jarząb, Roman Junik, Grzegorz Kamiński, Beata Kos-Kudła, Aldona Kowalska, Andrzej Lewiński, Beata Matyjaszek-Matuszek, Marek Ruchała, Lucyna Siemińska, Krzysztof Sworczak, Anhelli Syrenicz, Wojciech Zgliczyński

Vol 74, No 1 (2023)

Guidelines / Expert consensus

Pubmed: 36847719
Endokrynol Pol 2023;74(1):1-4.
Guidelines / Expert consensus2023, oct 23

Management of hypoparathyroidism: a Position Statement of the Expert Group of the Polish Society of Endocrinology

Waldemar Misiorowski, Marek Dedecjus, Jerzy Konstantynowicz, Arkadiusz Zygmunt, Beata Kos-Kudła, Andrzej Lewiński, Marek Ruchała, Wojciech Zgliczyński

Vol 74, No 5 (2023)

Guidelines / Expert consensus

Pubmed: 37902011
Endokrynol Pol 2023;74(5):447-467.
Review paper2023, feb 15

Clinical efficacy and safety of use of alfacalcidol and calcitriol in daily endocrinological practice

Michał Stuss, Marta Michalska-Kasiczak, Ewa Sewerynek

Vol 74, No 1 (2023)

Review paper

Pubmed: 36847721
Endokrynol Pol 2023;74(1):16-24.
Review paper2023, may 9

The influence of various endocrine disruptors on the reproductive system

Agata Czarnywojtek, Magdalena Borowska, Kamil Dyrka, Jakub Moskal, Jeremi Kościński, Iwona Krela-Kaźmierczak, Agnieszka Marta Lewandowska, Boushra Abou Hjeily, Paweł Gut, Karolina Hoffmann, Stefaan Van Gool, Nadia Sawicka-Gutaj, Marek Ruchała

Vol 74, No 3 (2023)

Review paper

Pubmed: 37695032
Endokrynol Pol 2023;74(3):221-233.
Review paper2023, apr 11

Thyroid organoids: Advances and applications

Jinlu Zhao, Yi Ren, Zhenzhong Ge, Xingyu Zhao, Wang Li, He Wang, Meng Jiang

Vol 74, No 2 (2023)

Review paper

Pubmed: 37039493
Endokrynol Pol 2023;74(2):121-127.
Review paper2023, oct 27

Mitophagy in tumor: foe or friend?

Li Li, Fei Hu

Vol 74, No 5 (2023)

Review paper

Pubmed: 37902014
Endokrynol Pol 2023;74(5):511-519.
Guidelines / Expert consensus2024, aug 19

Polish diagnostic and therapeutic recommendations for adrenocortical carcinoma

Daria Handkiewicz-Junak, Marek Dedecjus, Urszula Ambroziak, Marcin Barczyński, Lucyna Bednarek-Papierska, Ewa Chmielik, Andrzej Cichocki, Agnieszka Czarniecka, Jarosław Ćwikła, Kornelia Hasse-Lazar, Alicja Hubalewska-Dydejczyk, Joanna Januszkiewicz-Caulier, Barbara Jarząb, Grzegorz Kamiński, Małgorzata Karbownik-Lewińska, Agnieszka Kolasińska-Ćwikła, Łukasz Koperski, Beata Kos-Kudła, Agnieszka Kotecka-Blicharz, Aldona Kowalska, Jolanta Krajewska, Leszek Królicki, Andrzej Lewiński, Ilona Michałowska, Małgorzata Oczko-Wojciechowska, Marek Ruchała, Anhelli Syrenicz, Andrzej Tysarowski, Barbara Ziółkowska, Agnieszka Żyłka

Vol 75, No 4 (2024)

Guidelines / Expert consensus

Pubmed: 39279304
Endokrynol Pol 2024;75(4):339-358.
Review paper2023, jun 12

Impact of alirocumab/evolocumab on lipoprotein (a) concentrations in patients with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized controlled trials

Haibing Dai, Yonglin Zhu, Zuyi Chen, Renqing Yan, Jinsong Liu, Ziyun He, Lin Zhang, Feng Zhang, Shengkai Yan

Vol 74, No 3 (2023)

Review paper

Pubmed: 37335067
Endokrynol Pol 2023;74(3):234-242.
Review paper2023, nov 7

Obesity in perimenopause — current treatment options based on pathogenetic factors

Dominik Porada, Jakub Gołacki, Beata Matyjaszek-Matuszek

Vol 74, No 6 (2023)

Review paper

Pubmed: 37994584
Endokrynol Pol 2023;74(6):565-575.
Review paper2024, jun 6

Impact of trenbolone on selected organs

Rafał Borecki, Piotr Byczkiewicz, Jolanta Słowikowska-Hilczer

Vol 75, No 3 (2024)

Review paper

Pubmed: 38887114
Endokrynol Pol 2024;75(3):267-278.
Review paper2023, aug 17
Review paper2023, oct 23

Secondary hyperparathyroidism in chronic kidney disease: pathomechanism and current treatment possibilities

Małgorzata Rodzoń-Norwicz, Sebastian Norwicz, Magdalena Sowa-Kućma, Agnieszka Gala-Błądzińska

Vol 74, No 5 (2023)

Review paper

Pubmed: 37902013
Endokrynol Pol 2023;74(5):490-498.
Review paper2023, oct 9

Adipose tissue as a cause of endocrine dysfunction

Alina Ewa Kuryłowicz

Vol 74, No 5 (2023)

Review paper

Pubmed: 37902012
Endokrynol Pol 2023;74(5):468-479.
Original paper2023, mar 14

The role of vitamin D in women with Hashimoto’s thyroiditis

Marcin Gierach, Roman Junik

Vol 74, No 2 (2023)

Original paper

Pubmed: 36916543
Endokrynol Pol 2023;74(2):176-180.
Review paper2024, feb 21

Differential diagnosis of thyroid orbitopathy — diseases mimicking the presentation or activity of thyroid orbitopathy

Mariusz Nowak, Wojciech Nowak, Bogdan Marek, Beata Kos-Kudła, Lucyna Siemińska, Magdalena Londzin-Olesik, Dariusz Kajdaniuk

Vol 75, No 1 (2024)

Review paper

Pubmed: 38497384
Endokrynol Pol 2024;75(1):1-11.
Original paper2023, jan 18
Review paper2024, jul 24

Causes of difficulties with adequate levothyroxine substitution — an immunoendocrine perspective

Magdalena Łukawska-Tatarczuk, Edward Franek

Vol 75, No 4 (2024)

Review paper

Pubmed: 39279306
Endokrynol Pol 2024;75(4):366-384.
Original paper2023, apr 27

Efficacy of two different dosages of prednisone for treatment of subacute thyroiditis: a single-centre, prospective, randomized, open-label, non-inferiority trial

Yiqi Xu, Shu Liu, Xiaofan Zeng, Qian Wu, Yueping Chen, Chunling He, Qing Zhai, Binhua Zhang, Jialin Gao

Vol 74, No 2 (2023)

Original paper

Pubmed: 37155300
Endokrynol Pol 2023;74(2):168-175.
Review paper2023, jun 30

The influence of SGLT2 inhibitors on oxidative stress in heart failure and chronic kidney disease in patients with type 2 diabetes

Diana Nabrdalik-Leśniak, Katarzyna Nabrdalik, Krzysztof Irlik, Oliwia Janota, Hanna Kwiendacz, Paulina Szromek-Białek, Mirosław Maziarz, Tomasz Stompór, Janusz Gumprecht, Gregory Y. H. Lip

Vol 74, No 4 (2023)

Review paper

Pubmed: 37431873
Endokrynol Pol 2023;74(4):349-362.
Clinical vignette2023, may 8

Ectopic parathyroid adenoma in a patient with multiple endocrine tumours

Inês Lemos Damásio, Inês Patrocínio Carvalho, Sara de Miranda Lemos Donato Bento, Valeriano Alberto Pais Horta Leite

Vol 74, No 3 (2023)

Clinical vignette

Pubmed: 37155305
Endokrynol Pol 2023;74(3):344-345.
Original paper2023, may 8

MicroRNA-646 inhibits the proliferation of ovarian granulosa cells via insulin-like growth factor 1 (IGF-1) in polycystic ovarian syndrome (PCOS)

Jiali Lu, Feilan Xuan, Aixue Chen, Ruiying Jin, Weimei Zhou, Yongju Ye, Yuefang Ren

Vol 74, No 3 (2023)

Original paper

Pubmed: 37155307
Endokrynol Pol 2023;74(3):305-314.
Original paper2023, may 29
Original paper2023, nov 29

sh- Ambra1 inhibits IRS-1/PI3K/Akt signalling pathway to reduce autophagy in gestational diabetes

Xin Qu, Xiao-yan Li, Yan Feng, Xiaoli Wang, Lei Li, Yu-ping Wang, Yong-li Chu

Vol 75, No 1 (2024)

Original paper

Pubmed: 38497391
Endokrynol Pol 2024;75(1):61-70.